Aptilon Corporation announces grants of options



    MONTREAL, Dec. 24 /CNW/ - Aptilon Corporation (the "Corporation") (TSX
Venture Exchange: APZ), a leading provider of physician access through its
innovative alternative sales and marketing channel, announces that, on
December 21, 2007, it has granted an aggregate of 1,300,000 options to 19 of
its employees and consultants. None of these options were granted to directors
or officers of the Corporation. These options have an exercise price of $0.25
per share and a five year term and are subject to the terms and conditions of
the Corporation's stock option plan.

    About Aptilon Corporation
    -------------------------
    Aptilon enables pharmaceutical, biotech and medical device companies to
effectively reach and interact with physicians via the Internet through its
innovative AxcelRx Live video detailing (with company reps), virtual programs,
peer selling and other sales and marketing programs. Leading health care
companies have adopted Aptilon's model, driving tens of thousands of
high-quality rep-physician interactions averaging more than eight minutes in
length. Aptilon provides the infrastructure necessary for sales
representatives to build physician awareness, understanding and preference
during all stages of a product's life cycle, from pre-launch education through
end stage support. For more information, visit www.aptilon.com.

    Forward-looking Statements
    --------------------------
    This news release contains forward-looking information. These statements
relate to future events or future performance and reflect management's current
expectations and assumptions. Such forward-looking statements reflect
management's current beliefs and are based on information currently available
to management of Aptilon. A number of factors could cause actual events,
performance or results to differ materially from the events performance and
results discussed in the forward-looking statements. These forward-looking
statements are made as of the date hereof and Aptilon does not assume any
obligation to update or revise them to reflect new events or circumstances.

    The TSX Venture Exchange Inc. has not reviewed and does not accept
    responsibility for the adequacy or accuracy of this release.

    %SEDAR: 00022191EF




For further information:

For further information: Denis Martineau, President, Aptilon
Corporation, (514) 844-8866, dmartineau@aptilon.com; Arianna Vanin, Investor
Relations, The Equicom Group, (514) 844-4680, avanin@equicomgroup.com

Organization Profile

DMD Digital Health Connections Group Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890